SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results - Conference call scheduled for April 20, 2015 at 8:00 a.m. ET - BEIJING, April 20, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2014. Fourth] []

By | 2016-03-16T06:43:47+00:00 April 29th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

QUNR [Qunar Cayman Islands] 20-F: (Original Filing)

[* Not for trading, but only in connection with the listing on The NASDAQ Global Market of American depositary shares. Currently, one ADS represents three Class B ordinary shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the] [Place of Incorporation Subsidiaries Queen’s Road Investment Management Limited Hong Kong Beijing Qunar Software Technology Company Limited People’s Republic of China Shanghai Qianlima Network Technology Co., Ltd. People’s Republic of China Variable Interest Entity Qunar.com Beijing Information Technology Company Limited People’s Republic of China Subsidiaries of Variable Interest Entity Beijing Jiaxin Haoyuan Information Technology Company Ltd. People’s Republic of China] [I, Chenchao (CC) Zhuang, certify that: 1. I have reviewed this annual report on Form 20-F of Qunar Cayman Islands Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification by the Principal Financial Officer I, Sam Hanhui Sun, certify that: 1. I have reviewed this annual report on Form 20-F of Qunar Cayman Islands Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 EX-13.1 5 a15-6508_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29, 2015 EX-13.2 6 a15-6508_1ex13d2.htm EX-13.2] [15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-193539) pertaining to the Qunar Cayman Islands Limited Amended and Restated 2007 Share Plan of our reports dated April 29, 2015, with respect to the consolidated financial statements of Qunar Cayman Islands Limited and the effectiveness of internal]

OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)

[O2Micro Reports First Quarter 2015 Financial Results GEORGE TOWN, Grand Cayman, April 29, 2015 (GLOBE NEWSWIRE) -- Operational and Strategic Highlights Company experienced strong design activity in solutions for backlighting, general lighting, battery, smartphone and tablet markets; expecting products to continue to ramp in 2015 2 O Lower operating expense levels reflect new cash breakeven level estimate of $17.0-$18.0 million] [FORM 6-K April 2015 000-30910 O2Micro International Limited Grand Pavilion Commercial Centre, West Bay Road Note: Note: O2Micro International Limited Chief Executive Officer 6-K 1 document.htm FORM 6-K FILING DOCUMENT]

By | 2016-03-28T03:17:45+00:00 April 29th, 2015|Categories: Chinese Stocks, OIIM, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Fourth Quarter and Full Year

[Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results - Conference call scheduled for April 20, 2015 at 8:00 a.m. ET - BEIJING, April 20, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2014. Fourth] []

By | 2016-03-16T06:45:43+00:00 April 29th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

QUNR [Qunar Cayman Islands] 20-F: * Not for trading, but only in connection

[* Not for trading, but only in connection with the listing on The NASDAQ Global Market of American depositary shares. Currently, one ADS represents three Class B ordinary shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the] [Place of Incorporation Subsidiaries Queen’s Road Investment Management Limited Hong Kong Beijing Qunar Software Technology Company Limited People’s Republic of China Shanghai Qianlima Network Technology Co., Ltd. People’s Republic of China Variable Interest Entity Qunar.com Beijing Information Technology Company Limited People’s Republic of China Subsidiaries of Variable Interest Entity Beijing Jiaxin Haoyuan Information Technology Company Ltd. People’s Republic of China] [I, Chenchao (CC) Zhuang, certify that: 1. I have reviewed this annual report on Form 20-F of Qunar Cayman Islands Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification by the Principal Financial Officer I, Sam Hanhui Sun, certify that: 1. I have reviewed this annual report on Form 20-F of Qunar Cayman Islands Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 EX-13.1 5 a15-6508_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29, 2015 EX-13.2 6 a15-6508_1ex13d2.htm EX-13.2] [15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-193539) pertaining to the Qunar Cayman Islands Limited Amended and Restated 2007 Share Plan of our reports dated April 29, 2015, with respect to the consolidated financial statements of Qunar Cayman Islands Limited and the effectiveness of internal]

OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports First Quarter 2015 Financial Results GEORGE

[O2Micro Reports First Quarter 2015 Financial Results GEORGE TOWN, Grand Cayman, April 29, 2015 (GLOBE NEWSWIRE) -- Operational and Strategic Highlights Company experienced strong design activity in solutions for backlighting, general lighting, battery, smartphone and tablet markets; expecting products to continue to ramp in 2015 2 O Lower operating expense levels reflect new cash breakeven level estimate of $17.0-$18.0 million] [FORM 6-K April 2015 000-30910 O2Micro International Limited Grand Pavilion Commercial Centre, West Bay Road Note: Note: O2Micro International Limited Chief Executive Officer 6-K 1 document.htm FORM 6-K FILING DOCUMENT]

By | 2016-03-28T03:18:50+00:00 April 29th, 2015|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar